| 标题 |
Anti-TL1A antibody, afimkibart, in moderately-to-severely active ulcerative colitis (TUSCANY-2): a multicentre, double-blind, treat-through, multi-dose, randomised, placebo-controlled, phase 2b trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet Gastroenterology & Hepatology 作者:Silvio Danese; Jessica R. Allegretti; Stefan Schreiber; Laurent Peyrin‐Biroulet; Vipul Jairath; et al 出版日期:2025-07-21 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)